neoadjuvant and adjuvant chemotherapy

DRUG2 trials

Sponsors

Japan Clinical Oncology Group(JCOG), University of Jena

Conditions

Tumor Cell, Circulatingsoft tissue sarcoma

Phase 2

Neoadjuvant and adjuvant chemotherapy with ifosfamide and adriamycin for adult high-grade soft tissue sarcomas in the extremities (JCOG0304, Neoadjuvant and adjuvant chemotherapy with IFO/ADM phase II)

Active, not recruitingJPRN-C000000096

Japan Clinical Oncology Group(JCOG)soft tissue sarcoma

Start: 2004-03-01Target: 75Updated: 2026-06-29

Unknown Phase

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.

RecruitingNCT04902937

University of JenaTumor Cell, Circulating

Start: 2021-07-01End: 2026-12-31Target: 200Updated: 2023-11-28